Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?lookfor=%22Okpara%2C+Chinyere+E.%22&type=Person&sort=year
/vufind/Search/Results?lookfor=%22Okpara%2C+Chinyere+E.%22&type=Person&sort=year
Search /vufind/Search2/Results?lookfor=%22Okpara%2C+Chinyere+E.%22&type=Person&sort=year
PubPharm (13)
1
Lenvatinib Plus Pembrolizumab Versus Sunitinib in First-Line Treatment of Advanced Renal Cell Carcinoma : Final Prespecified Overall Survival Analysis of CLEAR, a Phase III Study
enthalten in:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
| 2024
von
Motzer, R.
|
Porta, C.
|
Eto, M.
| +134
Wird geladen...
2
Pembrolizumab with or Without Lenvatinib as First-line Therapy for Patients with Advanced Urothelial Carcinoma (LEAP-011) : A Phase 3, Randomized, Double-Blind Trial
enthalten in:
European urology
| 2024
von
Matsubara, N.
|
de Wit, R.
|
Balar, A.
| +18
Wird geladen...
3
Characterization and Management of Adverse Reactions in Patients With Advanced Endometrial Cancer Receiving Lenvatinib Plus Pembrolizumab
enthalten in:
The oncologist
| 2024
von
Colombo, N.
|
Lorusso, D.
|
Monk, B.
| +8
Wird geladen...
4
Pembrolizumab With or Without Lenvatinib for First-Line Metastatic NSCLC With Programmed Cell Death-Ligand 1 Tumor Proportion Score of at least 1% (LEAP-007) : A Randomized, Double-Blind, Phase 3 Trial
enthalten in:
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
| 2023
von
Yang, J.
|
Han, B.
|
De La Mora Jiménez, E.
| +16
Wird geladen...
5
Corrigendum : Phase 3 CLEAR study in patients with advanced renal cell carcinoma: outcomes in subgroups for the lenvatinib-plus-pembrolizumab and sunitinib arms
enthalten in:
Frontiers in oncology
| 2023
von
Grünwald, V.
|
Powles, T.
|
Eto, M.
| +18
ErratumFor: Front Oncol. 2023 Aug 16;13:1223282. - PMID 37664025
Wird geladen...
6
Phase 3 CLEAR study in patients with advanced renal cell carcinoma : outcomes in subgroups for the lenvatinib-plus-pembrolizumab and sunitinib arms
enthalten in:
Frontiers in oncology
| 2023
von
Grünwald, V.
|
Powles, T.
|
Eto, M.
| +18
ErratumIn: Front Oncol. 2024 Mar 01;13:1343027. - PMID 38495081
Wird geladen...
7
Paediatric Strategy Forum for medicinal product development of multi-targeted kinase inhibitors in bone sarcomas : ACCELERATE in collaboration with the European Medicines Agency with participation of the Food and Drug Administration
enthalten in:
European journal of cancer (Oxford, England : 1990)
| 2022
von
Pearson, A.
|
Gaspar, N.
|
Janeway, K.
| +40
Wird geladen...
8
Lenvatinib dose, efficacy, and safety in the treatment of multiple malignancies
enthalten in:
Expert review of anticancer therapy
| 2022
von
Motzer, R.
|
Taylor, M.
|
Evans, T.
| +10
Wird geladen...
9
OLIE, ITCC-082 : a Phase II trial of lenvatinib plus ifosfamide and etoposide in relapsed/refractory osteosarcoma
enthalten in:
Future oncology (London, England)
| 2021
von
Gaspar, N.
|
Campbell-Hewson, Q.
|
Huang, J.
| +2
Wird geladen...
10
Lenvatinib with etoposide plus ifosfamide in patients with refractory or relapsed osteosarcoma (ITCC-050) : a multicentre, open-label, multicohort, phase 1/2 study
enthalten in:
The Lancet. Oncology
| 2021
von
Gaspar, N.
|
Venkatramani, R.
|
Hecker-Nolting, S.
| +19
CommentIn: Lancet Oncol. 2021 Sep;22(9):1206-1207. - PMID 34416160
Wird geladen...
1
2
Nächster »
[2]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Medienart
13
Aufsätze
13
E-Artikel
13
E-Ressourcen
Zeitschriftentitel
2
Frontiers in oncology
2
The Lancet. Oncology
1
European journal of cancer (Oxford, England : 1...
1
European urology
1
Expert review of anticancer therapy
1
Future oncology (London, England)
1
Journal of clinical oncology : official journal...
1
Journal of thoracic oncology : official publica...
1
The oncologist
1
bioRxiv.org
1
eLife
Alle anzeigen ...
weniger ...
Thema
11
Journal Article
9
lenvatinib
7
EE083865G2
7
pembrolizumab
6
Phenylurea Compounds
6
Quinolines
5
Research Support, Non-U.S. Gov't
4
DPT0O3T46P
4
Protein Kinase Inhibitors
3
Antibodies, Monoclonal, Humanized
3
Clinical Trial, Phase II
3
Multicenter Study
3
Randomized Controlled Trial
3
renal cell carcinoma
2
6PLQ3CP4P3
2
Clinical Trial, Phase I
2
Clinical Trial, Phase III
2
Etoposide
2
Ifosfamide
2
Lenvatinib
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
3
2024
3
2023
2
2022
3
2021
2
2020
Alle anzeigen ...
weniger ...
Erscheinungsjahr(e)
Von:
Bis:
Sprache
13
Englisch
Haven't found what you're looking for?
Wird geladen...